| Literature DB >> 16297498 |
Abstract
The realisation of the full potential of products based on stem cells in a clinical setting demands robust scientific evidence, underpinned by legitimate regulatory requirements to ensure their safety and efficacy. This review examines the legal aspects of the use of stem cells in the laboratory and in the development of new therapies and pharmaceutical products. UK and European legal and regulatory documents and directives are used as the framework for discussion of the current status and future prospects.Entities:
Keywords: Biomedical and Behavioral Research; European Commission; European Convention on Human Rights and Biomedicine; European Group on Ethics in Science and New Technologies; Genetics and Reproduction; Health Care and Public Health; Human Fertilisation and Embryology Act 1990 (Great Britain); Legal Approach
Mesh：
Year: 2005 PMID： 16297498 DOI： 10.1016/j.addr.2005.08.005
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN： 0169-409X Impact factor: 15.470